Eli Lilly’s Zepbound single-dose vials will expand access to more patients: Mizuho’s Jared Holz

Jared Holz, Mizuho Securities healthcare equity strategist, joins ‘Squawk Box’ to discuss Eli Lilly’s announcement to release single-dose vials of its anti-obesity drug Zepbound, how the news will expand access to the drug, state of the obesity drug market, and more.